Posted on 27.09.2016
Quivium was an international coup for Discovery Park, after successfully securing a £500,000 loan from Expansion East Kent, to bring its asthma treatment device to the UK.
The funding from the Regional Growth Fund – together with the support of investment promotion agency, Locate in Kent brought the leading science hub to the company’s attention.
Discovery Park’s world class facilities and collaboration between companies on site sealed the deal for the start up healthcare technology company, based on the US east coast city of Boston. They moved on site at the beginning of 2015, the 100th tenant to do so.
Quivium, which make sensors that alert asthma patients when they are about to have an attack, felt Discovery Park with its facilities was the best place to win a share of the UK market for its products. The move created an initial 20 jobs.
The company has developed a wearable device, which predicts the onset of an asthma attack before it occures by analysing breathing and coughing. The device is set for launch in Asia this autumn, Hong Kong later this year with the US and Europe to follow once regulatory steps are overcome.
Steve Schmidt, the company founder and Chief Executive, said:
“Bringing our sensors to the UK presents a huge opportunity for us and we’re delighted to make Sandwich our UK home.
“Like other manufacturing, science and tech industries, we feel we are ideally placed here to maximise our potential in the UK and Europe.
Discovery Park provided the right mix of infrastructure, resources, and collaborative opportunities, making it the obvious choice.”